Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alvimopan in Opioid-Induced Postoperative Bowel Dysfunction
NCT00388258Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Mar 2001
- Primary completion
- Dec 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of alvimopan in postoperative ileus (POI), sponsored by Merck & Co.. Started Mar 2001; status: completed.
02
Drugs
alvimopan
03
Conditions
postoperative ileus (POI)
Beyond the preview
Go deeper on NCT00388258.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00388258.